Hornetcorn

About:

Hornetcorn specializes in human cell storage, cell drug, clinical research and application.

Top Investors: Shenzhen Capital Group, Futian Investment Holdings, Chuangsai Fund Investment Management, Shenzhen Hongtu Shengwu Chuangtou

Description:

Hornetcorn specializes in the research, development, and service of tumour-specific immune cells and gene technologies. They focus on cell technology research and development, clinical research, clinical application, and technical services.

Total Funding Amount:

21.4M CNY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Shenzhen, Guangdong, China

Founded Date:

2010-11-29

Contact Email:

hornetcorn(AT)hornetcorn.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2014-01-13

IPO Status:

Public

Industries: